Statements (25)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
erythropoiesis-stimulating agent biosimilar |
gptkbp:approvedBy |
gptkb:European_Union
|
gptkbp:ATCCode |
B03XA01
|
gptkbp:contraindication |
uncontrolled hypertension
hypersensitivity to epoetin zeta |
gptkbp:developedBy |
gptkb:STADA_Arzneimittel
gptkb:Hospira |
https://www.w3.org/2000/01/rdf-schema#label |
epoetin zeta
|
gptkbp:legalStatus |
prescription only
|
gptkbp:marketedAs |
Retacrit
Silapo |
gptkbp:mechanismOfAction |
stimulates erythropoiesis
|
gptkbp:relatedTo |
gptkb:erythropoietin
|
gptkbp:routeOfAdministration |
subcutaneous
intravenous |
gptkbp:sideEffect |
hypertension
flu-like symptoms thromboembolic events |
gptkbp:usedFor |
treatment of anemia
anemia in chronic kidney disease anemia in cancer patients undergoing chemotherapy |
gptkbp:bfsParent |
gptkb:erythropoietin
|
gptkbp:bfsLayer |
6
|